Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paesmans

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapyA Cometta, W V Kern, R De Bock, et al.
Breast Cancer Research and Treatment|November 30, 2004
HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxelA Di Leo, S Chan, M Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancerM J Piccart, A Di Leo, M Beauduin, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer|May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul, J L Lagrange, S Theobald, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapyA Cometta, W V Kern, R De Bock, et al.
Breast Cancer Research and Treatment|November 30, 2004
HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxelA Di Leo, S Chan, M Paesmans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancerM J Piccart, A Di Leo, M Beauduin, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer|May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul, J L Lagrange, S Theobald, et al.
Pageof 19